Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine Add-on in Neuromyelitis Optica
NCT02865018Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Apr 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cetirizine in neuromyelitis optica (NMO), sponsored by Icahn School of Medicine at Mount Sinai. Started Apr 2014; status: completed.
02
Drugs
cetirizine
03
Conditions
neuromyelitis optica (NMO)
Beyond the preview
Go deeper on NCT02865018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865018.